Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for infant feeding refusal disorder
IRCT20190410043224N4Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Avoidant/Restrictive Food Intake Disorder (ARFID) comparing Gabapentin with Placebo (2 arms). Primary endpoints: Effective breastfeeding frequency, Formula intake volume and 4 more. Started Feb 2021; status: completed.
02
Drugs
gabapentin
03
Conditions
Avoidant/Restrictive Food Intake Disorder (ARFID)
Beyond the preview
Go deeper on IRCT20190410043224N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190410043224N4.